Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization-Reference-Cited by-同舟云学术

Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization

Published:2021-03-08 Issue:8 Volume:17 Page:887-902
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Burnett Sarah D.¹,Blanchette Alexander D¹,Chiu Weihsueh A.¹,Rusyn Ivan¹

Affiliation:

1. Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA

Funder

National Institutes of Health

United States Environmental Protection Agency

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2021.1894122

Reference155 articles.

1. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

2. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

3. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the american heart association. Circulation 2019;139:e56–e528.

4. Combined lifestyle factors, all-cause mortality and cardiovascular disease: a systematic review and meta-analysis of prospective cohort studies

5. Cardiovascular disease: The rise of the genetic risk score

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions;Frontiers in Physiology;2024-09-12

2. Characterizing PFAS hazards and risks: a human population-based in vitro cardiotoxicity assessment strategy;Human Genomics;2024-09-02

3. An in vitro-in silico workflow for predicting renal clearance of PFAS;Toxicology and Applied Pharmacology;2024-08

4. Informing Hazard Identification and Risk Characterization of Environmental Chemicals by Combining Transcriptomic and Functional Data from Human-Induced Pluripotent Stem-Cell-Derived Cardiomyocytes;Chemical Research in Toxicology;2024-07-24

5. In vitro to in vivo extrapolation from 3D hiPSC-derived cardiac microtissues and physiologically based pharmacokinetic modeling to inform next-generation arrhythmia risk assessment;Toxicological Sciences;2024-06-19